For treating acquired immune deficiency syndrome (AIDS) and acute myeloid leukemia (AML), CRISPR-Cas9 was employed to knock out the CCR5 gene in donor HSPCs, which were then transplanted into patients with HIV-associated AML. This evidence concerns the gene CCR5 and AIDS.